Tempest Therapeutics, Inc. Income (Loss) from Equity Method Investments
Tempest Therapeutics, Inc. (TPST) reported Income (Loss) from Equity Method Investments of -$2.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2018-11-09
- Tempest Therapeutics, Inc. income (loss) from equity method investments for the quarter ending 2018-09-30 was -$2.00K.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for the quarter ending 2018-06-30 was -$4.00K.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for the quarter ending 2018-03-31 was $0.00.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for the quarter ending 2017-12-31 was -$3.00K.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for fiscal 2017 was -$1.02M.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for fiscal 2016 was -$1.54M.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for fiscal 2015 was -$1.56M.
- Tempest Therapeutics, Inc. income (loss) from equity method investments for fiscal 2014 was -$1.58M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 36 month |
|---|---|---|---|---|---|
| 2018-09-30 | -$2.00K 10-Q · filed 2018-11-09 | -$6.00K derived: sum of 2 quarters · filed 2018-11-09 | -$6.00K 10-Q · filed 2018-11-09 | -$9.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-06-30 | -$4.00K 10-Q · filed 2018-08-09 | -$4.00K 10-Q · filed 2018-08-09 | -$7.00K derived: sum of 3 quarters · filed 2018-08-09 | -$147.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 | -$3.00K derived: sum of 2 quarters · filed 2018-05-03 | -$143.00K derived: sum of 3 quarters · filed 2018-11-09 | -$597.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$143.00K derived: sum of 2 quarters · filed 2018-11-09 | -$597.00K derived: sum of 3 quarters · filed 2018-11-09 | -$1.02M 10-K · filed 2018-03-15 | |
| 2017-09-30 | -$140.00K 10-Q · filed 2018-11-09 | -$594.00K derived: sum of 2 quarters · filed 2018-11-09 | -$1.01M 10-Q · filed 2018-11-09 | -$1.39M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | -$454.00K 10-Q · filed 2018-08-09 | -$875.00K 10-Q · filed 2018-08-09 | -$1.25M derived: sum of 3 quarters · filed 2018-08-09 | -$1.61M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$421.00K 10-Q · filed 2018-05-03 | -$792.00K derived: sum of 2 quarters · filed 2018-05-03 | -$1.16M derived: sum of 3 quarters · filed 2018-05-03 | -$1.57M derived: sum of 4 quarters · filed 2018-05-03 | |
| 2016-12-31 | -$371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$735.00K derived: sum of 2 quarters · filed 2018-03-15 | -$1.15M derived: sum of 3 quarters · filed 2018-03-15 | -$1.54M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$364.00K 10-Q · filed 2017-11-02 | -$780.00K derived: sum of 2 quarters · filed 2017-11-02 | -$1.17M 10-Q · filed 2017-11-02 | -$1.56M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | -$416.00K 10-Q · filed 2016-08-04 | -$807.00K 10-Q · filed 2017-08-03 | -$1.19M derived: sum of 3 quarters · filed 2018-03-15 | -$1.51M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-03-31 | -$391.00K 10-Q · filed 2017-05-09 | -$776.00K derived: sum of 2 quarters · filed 2018-03-15 | -$1.09M derived: sum of 3 quarters · filed 2018-03-15 | -$1.48M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-12-31 | -$385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$701.00K derived: sum of 2 quarters · filed 2018-03-15 | -$1.09M derived: sum of 3 quarters · filed 2018-03-15 | -$1.56M 10-K · filed 2018-03-15 | |
| 2015-09-30 | -$316.00K 10-Q · filed 2016-11-03 | -$705.00K derived: sum of 2 quarters · filed 2016-11-03 | -$1.18M 10-Q · filed 2016-11-03 | -$1.84M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-06-30 | -$389.00K 10-Q · filed 2016-08-04 | -$860.00K 10-Q · filed 2016-08-04 | -$1.53M derived: sum of 3 quarters · filed 2017-03-02 | -$2.05M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-03-31 | -$471.00K 10-Q · filed 2016-05-05 | -$1.14M derived: sum of 2 quarters · filed 2017-03-02 | -$1.66M derived: sum of 3 quarters · filed 2017-03-02 | -$1.96M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2014-12-31 | -$668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$1.19M derived: sum of 2 quarters · filed 2017-03-02 | -$1.49M derived: sum of 3 quarters · filed 2017-03-02 | -$1.58M 10-K · filed 2017-03-02 | |
| 2014-09-30 | -$523.00K 10-Q · filed 2015-11-05 | -$818.00K derived: sum of 2 quarters · filed 2015-11-05 | -$915.00K 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$295.00K 10-Q · filed 2015-08-10 | -$392.00K 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | -$97.00K 10-Q · filed 2015-05-11 | -$97.00K 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |